Washington, September 18 -- In a bid to help low-income countries, the United States is all set to donate its 10 percent supply of the pandemic H1N1 influenza vaccine to the World Health Organization (WHO). The White House revealed that it is taking this action in concert with eight other countries.
Trenton, NJ, September 17 -- The Food and Drug Administration (FDA) has asked the makers of injected promethazine, a tranquillizer also used to treat nausea and vomiting, to put the sternest warning possible on the drug because it can cause tissue damage leading to amputation.
Columbia, SC, September 15 -- A new research highlights the potential dangers of antibiotics being within the easy reach of consumers on the Internet, without the benefits of a prescription.
Salem, OR, September 16 -- According to a latest study, medications that reduce the risk of breast cancer
actually pose many other health risks.
New York, September 15 -- A new research suggests that a combination of widely used diabetes drug metformin and conventional chemotherapy -- treatment of disease by chemicals that kill cancerous cells -- promises a more effective way to treat breast cancer and prevent its recurrence.
New York, September 10 -- Mountain View, California-based Vivus Incorporation's weight-loss drug Qnexa produced strong results in two late-stage clinical trials.
Berlin, September 8 -- A new study quells one of the common myths and misconceptions related to oral contraceptives - that they can actually cause infertility if taken regularly or for ‘too long’.
Washington, September 5 -- Cervarix, a vaccine developed by GlaxoSmithKline Biologicals for treating human papilloma virus (HPV), will be reviewed for a probable sanction by the Food and Drug Administration (FDA) advisory committee on Wednesday in Washington.
Barcelona, August 31 -- Researchers from Sweden have discovered that a new drug ‘Brilinta’ developed by AstraZeneca PLC, a leading pharmacy company, is more effective in curing heart attacks and preventing sudden deaths due to strokes in heart patients.
Seattle, August 26: A new study has established that the prolonged use of tamoxifen can have adverse impact and can lead to an enhanced risk of recurrence of a sub type of breast cancer. Tamoxifen however, lowered the risk of any second breast cancer.
